Latest Updates
|
October 2011 Marketed Drug
Updates and Additions
|
Brand Name
|
Generic Name
|
Other Designation
|
| Nexavar |
Sorafenib tosylate |
BAY 43-9006 |
Sprycel |
Dasatinib |
BMS-354825 |
Yervoy |
Ipilimumab |
MDX-010, MDX-CTLA4; BMS-734016 |
Revlimid (formerly Revimid), Lenalidomide-Celgene Europe |
Lenalidomide |
CDC501, CDC-501, CDC-5013, CC5013, CC-5013 |
Valstar, Valtaxin (Canada) |
Valrubicin |
AD32 |
Herceptin |
Trastuzumab |
RG597, formerly rhuMAb HER2 |
Avastin |
Bevacizumab |
rhuMAb-VEGF, NSC-704865, R435, RG435 |
Velcade |
Bortezomib |
MLN341 (formerly LDP-341, PS-341 & MG-341) |
Glutoxim (Russia) |
|
BAM-002, NOV-002 (USA) |
Photofrin (North America), Photobarr (Europe) |
Porfimer sodium |
|
Mepact (Europe), formerly Junovan (USA) |
Mifamurtide |
Liposomal muramyl tripeptide phosphatidyl ethanolamine (L-MTP-PE), formerly CGP-19835A |
|
NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE: 1-949-830-0448 FAX: 1-949-830-0887
INFO@NEWMEDINC.COM
|